메뉴 건너뛰기




Volumn 144, Issue , 2009, Pages 497-537

Cellular adoptive immunotherapy after autologous and allogeneic hematopoietic stem cell transplantation

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL KILLER CELL RECEPTOR;

EID: 77953666199     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78580-6_20     Document Type: Review
Times cited : (2)

References (185)
  • 1
    • 84965088261 scopus 로고
    • Treatment of murine leukaemia with x-rays and homologous bone marrow
    • Barnes D, Loutit J. Treatment of murine leukaemia with x-rays and homologous bone marrow. Br J Haematol. 1957;3:241-252
    • (1957) Br J Haematol , vol.3 , pp. 241-252
    • Barnes, D.1    Loutit, J.2
  • 3
    • 0025678601 scopus 로고
    • Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
    • Kolb H, Mittermuller J, Clemm C, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990;76:2462-2465
    • (1990) Blood , vol.76 , pp. 2462-2465
    • Kolb, H.1    Mittermuller, J.2    Clemm, C.3    Holler, E.4    Ledderose, G.5    Brehm, G.6    Heim, M.7    Wilmanns, W.8
  • 4
    • 23444449333 scopus 로고
    • Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia
    • Porter D, Roth M, McGarigle C, Ferrara J, Antin J. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl JMed. 1994;330:100-106
    • (1994) N Engl JMed , vol.330 , pp. 100-106
    • Porter, D.1    Roth, M.2    McGarigle, C.3    Ferrara, J.4    Antin, J.5
  • 9
    • 36849048316 scopus 로고    scopus 로고
    • Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: A retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party
    • Schmid C, Labopin M, Nagler A, Bornhauser M, Finke J, Fassas A, Volin L, Gurman G, Maertens J, Bordigoni P, Holler E, Ehninger G, Polge E, Gorin NC, Kolb HJ, Rocha V. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin Oncol. 2007;25:4938-4945
    • (2007) J Clin Oncol , vol.25 , pp. 4938-4945
    • Schmid, C.1    Labopin, M.2    Nagler, A.3    Bornhauser, M.4    Finke, J.5    Fassas, A.6    Volin, L.7    Gurman, G.8    Maertens, J.9    Bordigoni, P.10    Holler, E.11    Ehninger, G.12    Polge, E.13    Gorin, N.C.14    Kolb, H.J.15    Rocha, V.16
  • 10
    • 8844228179 scopus 로고    scopus 로고
    • Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: A high incidence of isolated extramedullary relapse
    • Choi SJ, Lee JH, Kim S, Seol M, Lee YS, Lee JS, Kim WK, Chi HS, Lee KH. Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse. Leukemia 2004;18:1789-1797
    • (2004) Leukemia , vol.18 , pp. 1789-1797
    • Choi, S.J.1    Lee, J.H.2    Kim, S.3    Seol, M.4    Lee, Y.S.5    Lee, J.S.6    Kim, W.K.7    Chi, H.S.8    Lee, K.H.9
  • 13
    • 0030815867 scopus 로고    scopus 로고
    • Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation
    • Lokhorst HM, Schattenberg A, Cornelissen JJ, Thomas LL, Verdonck LF. Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. Blood 1997;90:4206-4211
    • (1997) Blood , vol.90 , pp. 4206-4211
    • Lokhorst, H.M.1    Schattenberg, A.2    Cornelissen, J.J.3    Thomas, L.L.4    Verdonck, L.F.5
  • 14
    • 0033844816 scopus 로고    scopus 로고
    • Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: Predictive factors for response and long-term outcome
    • Lokhorst HM, Schattenberg A, Cornelissen JJ, van Oers MH, Fibbe W, Russell I, Donk NW, Verdonck LF. Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome. J Clin Oncol. 2000;18:3031-3037
    • (2000) J Clin Oncol , vol.18 , pp. 3031-3037
    • Lokhorst, H.M.1    Schattenberg, A.2    Cornelissen, J.J.3    Van Oers, M.H.4    Fibbe, W.5    Russell, I.6    Donk, N.W.7    Verdonck, L.F.8
  • 16
    • 0003285638 scopus 로고    scopus 로고
    • Long-term follow-up of 55 patients who achieved complete remission (CR) after donor leukocyte infusions (DLI) for relapse after allogeneic bone marrow transplantation (BMT)
    • Porter D, Collins R, Drobyski W, Connors J, Van Hoef M, Antin J. Long-term follow-up of 55 patients who achieved complete remission (CR) after donor leukocyte infusions (DLI) for relapse after allogeneic bone marrow transplantation (BMT). Blood 1997; 90:549a.
    • (1997) Blood , vol.90
    • Porter, D.1    Collins, R.2    Drobyski, W.3    Connors, J.4    Van Hoef, M.5    Antin, J.6
  • 19
    • 0035092803 scopus 로고    scopus 로고
    • The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse
    • Carlens S, Remberger M, Aschan J, Ringden O. The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse. Biol Blood Marrow Transplant. 2001;7:31-38
    • (2001) Biol Blood Marrow Transplant , vol.7 , pp. 31-38
    • Carlens, S.1    Remberger, M.2    Aschan, J.3    Ringden, O.4
  • 21
    • 0029904695 scopus 로고    scopus 로고
    • Adoptive immunotherapy with donormononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation
    • Porter D, Roth M, Lee S,McGarigle C, Ferrara J, Antin J. Adoptive immunotherapy with donormononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1996;18:975-980
    • (1996) Bone Marrow Transplant , vol.18 , pp. 975-980
    • Porter, D.1    Roth, M.2    Lee, S.3    McGarigle, C.4    Ferrara, J.5    Antin, J.6
  • 22
    • 0027509704 scopus 로고
    • Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT
    • Szer J, Grigg A, Phillipos G, Sheridan W. Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT. Bone Marrow Transplant. 1993;11:109-111
    • (1993) Bone Marrow Transplant , vol.11 , pp. 109-111
    • Szer, J.1    Grigg, A.2    Phillipos, G.3    Sheridan, W.4
  • 23
    • 33750436958 scopus 로고    scopus 로고
    • Extramedullary sites of leukemia relapse after transplant
    • Cunningham I. Extramedullary sites of leukemia relapse after transplant. Leuk Lymphoma. 2007;47:1754-1767
    • (2007) Leuk Lymphoma , vol.47 , pp. 1754-1767
    • Cunningham, I.1
  • 24
    • 0033759082 scopus 로고    scopus 로고
    • Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy
    • Chong G, Byrnes G, Szer J, Grigg A. Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy. Bone Marrow Transplant. 1011;26:1011-1015
    • Bone Marrow Transplant , vol.1011 , Issue.26 , pp. 1011-1015
    • Chong, G.1    Byrnes, G.2    Szer, J.3    Grigg, A.4
  • 25
    • 0028915642 scopus 로고
    • Adoptive immunotherapy for relapsed leukemia following allogeneic bone marrow transplantation
    • Porter D, Antin J. Adoptive immunotherapy for relapsed leukemia following allogeneic bone marrow transplantation. Leuk Lymphoma. 1995;17:191-197
    • (1995) Leuk Lymphoma , vol.17 , pp. 191-197
    • Porter, D.1    Antin, J.2
  • 26
    • 1842433581 scopus 로고    scopus 로고
    • Societe francaise de greffe de moelle et therapie c. donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome
    • Depil S, Deconinck E, Milpied N, Sutton L, Witz F, Jouet JP, Damaj G, Yakoub-Agha I, Societe Francaise de Greffe de Moelle et Therapie c. Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome. Bone Marrow Transplant. 2004;33:531-534
    • (2004) Bone Marrow Transplant , vol.33 , pp. 531-534
    • Depil, S.1    Deconinck, E.2    Milpied, N.3    Sutton, L.4    Witz, F.5    Jouet, J.P.6    Damaj, G.7    Yakoub-Agha, I.8
  • 27
    • 0036223371 scopus 로고    scopus 로고
    • Donor lymphocyte infusion: The use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation
    • Slavin S, Morecki S, Weiss L, Or R. Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation. J Hematother Stem Cell Res. 2002;11:265-276
    • (2002) J Hematother Stem Cell Res , vol.11 , pp. 265-276
    • Slavin, S.1    Morecki, S.2    Weiss, L.3    Or, R.4
  • 28
    • 22744448681 scopus 로고    scopus 로고
    • Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: A prospective study
    • Choi SJ, Lee JH, Kim S, Lee YS, Seol M, Ryu SG, Lee JS, Kim WK, Jang S, Park CJ, Chi HS, Lee KH. Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study. Bone Marrow Transplant. 2005;36:163-169
    • (2005) Bone Marrow Transplant , vol.36 , pp. 163-169
    • Choi, S.J.1    Lee, J.H.2    Kim, S.3    Lee, Y.S.4    Seol, M.5    Ryu, S.G.6    Lee, J.S.7    Kim, W.K.8    Jang, S.9    Park, C.J.10    Chi, H.S.11    Lee, K.H.12
  • 33
    • 8644231815 scopus 로고    scopus 로고
    • Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma
    • Kroger N, ShimoniA, ZagrivnajaM,Ayuk F, Lioznov M, Schieder H, Renges H, Fehse B, Zabelina T, Nagler A, Zander AR. Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma. Blood 2004;104:3361-3363
    • (2004) Blood , vol.104 , pp. 3361-3363
    • Kroger, N.1    Shimoni, A.2    Zagrivnaja, M.3    Ayuk, F.4    Lioznov, M.5    Schieder, H.6    Renges, H.7    Fehse, B.8    Zabelina, T.9    Nagler, A.10    Zander, A.R.11
  • 34
    • 0028074547 scopus 로고
    • Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patientswith non-Hodgkin's lymphoma
    • Ratanatharathorn V, Uberti J, Karanes C, Abella E, Lum LG, Momin F, Cummings G, Sensenbrenner LL. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patientswith non-Hodgkin's lymphoma. Blood 1994;84:1050-1055
    • (1994) Blood , vol.84 , pp. 1050-1055
    • Ratanatharathorn, V.1    Uberti, J.2    Karanes, C.3    Abella, E.4    Lum, L.G.5    Momin, F.6    Cummings, G.7    Sensenbrenner, L.L.8
  • 35
    • 0026064277 scopus 로고
    • Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation
    • Jones R, Ambinder R, Piantadosi S, Santos G. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 1991;77:649-653
    • (1991) Blood , vol.77 , pp. 649-653
    • Jones, R.1    Ambinder, R.2    Piantadosi, S.3    Santos, G.4
  • 37
    • 0037114621 scopus 로고    scopus 로고
    • Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced intensity allogeneic progenitor cell transplantation: An analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation
    • Robinson S,GoldstoneAH,Mackinnon S, CarellaA,RussellN,DeElviraR, TaghipourG, Schmitz N. Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation. Blood 2002;100:4310-4316
    • (2002) Blood , vol.100 , pp. 4310-4316
    • Robinson, S.1    Goldstone, A.H.2    MacKinnon, S.3    Carella, A.4    Russell, N.5    De Elvira, R.6    Taghipour, G.7    Schmitz, N.8
  • 38
    • 0038751726 scopus 로고    scopus 로고
    • GVHD: Graft-versus host disease or graft-versus Hodgkin's disease? An old acronym with new meaning
    • Porter D, Stadtmauer EA, Lazarus H. "GVHD": graft-versus host disease or graft-versus Hodgkin's disease? An old acronym with new meaning. Bone Marrow Transplant. 2003;31:739-746
    • (2003) Bone Marrow Transplant , vol.31 , pp. 739-746
    • Porter, D.1    Stadtmauer, E.A.2    Lazarus, H.3
  • 41
    • 33646785047 scopus 로고    scopus 로고
    • Reduced intensity conditioning for allogeneic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: Where do we stand?
    • Anderlini P, Champlin RE. Reduced intensity conditioning for allogeneic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: where do we stand? Biol Blood Marrow Transplant. 2006;12:599-602.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 599-602
    • Anderlini, P.1    Champlin, R.E.2
  • 42
    • 33646679596 scopus 로고    scopus 로고
    • Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation
    • Loren A, Porter D. Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation. Curr Opin Oncol. 2006;18:107-114
    • (2006) Curr Opin Oncol , vol.18 , pp. 107-114
    • Loren, A.1    Porter, D.2
  • 45
    • 0001907486 scopus 로고    scopus 로고
    • Adoptive immunotherapy in bone marrow transplantation
    • Burakoff S, Deeg H, Ferrara J, editors. New York: Marcel Dekker
    • Porter D, Antin J. Adoptive immunotherapy in bone marrow transplantation. In: Burakoff S, Deeg H, Ferrara J, editors. Graft-versus-host disease. New York: Marcel Dekker; 1997. p. 733-754
    • (1997) Graft-versus-host Disease , pp. 733-754
    • Porter, D.1    Antin, J.2
  • 46
    • 0029092530 scopus 로고
    • Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: Separation of graft-versus-leukemia responses from graft-versus-host disease
    • Mackinnon S, Papadopoulos E, Carabasi M, Reich L, Collins N, Boulad F, Castro- Malaspina H, Childs B, Gillio A, Kernan N, Small T, Young J, O'Reilly R. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995;86:1261-1268
    • (1995) Blood , vol.86 , pp. 1261-1268
    • MacKinnon, S.1    Papadopoulos, E.2    Carabasi, M.3    Reich, L.4    Collins, N.5    Boulad, F.6    Castro- Malaspina, H.7    Childs, B.8    Gillio, A.9    Kernan, N.10    Small, T.11    Young, J.12    O'Reilly, R.13
  • 47
    • 77953662564 scopus 로고    scopus 로고
    • GVHD and GVL after donor leukocyte infusion
    • Porter D, Levine J. GVHD and GVL after donor leukocyte infusion. Semin Hematol. 2007;43:53-61.
    • (2007) Semin Hematol , vol.43 , pp. 53-61
    • Porter, D.1    Levine, J.2
  • 48
    • 0030642156 scopus 로고    scopus 로고
    • Graft-versus-leukemia effect of allogeneic bone marrow transplantation and donor mononuclear cell infusions
    • Winter J, editor. Norwell: Kluwer Academic Publishers
    • Porter D, Antin J. Graft-versus-leukemia effect of allogeneic bone marrow transplantation and donor mononuclear cell infusions. In: Winter J, editor. Blood stem cell transplantation. Norwell: Kluwer Academic Publishers; 1997. p. 57-86.
    • (1997) Blood Stem Cell Transplantation , pp. 57-86
    • Porter, D.1    Antin, J.2
  • 49
    • 1342308959 scopus 로고    scopus 로고
    • Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation
    • Chiorean EG, DeFor TE, Weisdorf DJ, Blazar BR, McGlave PB, Burns LJ, Brown C, Miller JS. Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2004;10:171-177
    • (2004) Biol Blood Marrow Transplant , vol.10 , pp. 171-177
    • Chiorean, E.G.1    De For, T.E.2    Weisdorf, D.J.3    Blazar, B.R.4    McGlave, P.B.5    Burns, L.J.6    Brown, C.7    Miller, J.S.8
  • 52
    • 12944328008 scopus 로고    scopus 로고
    • Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: Prophylactic infusion of EBV-specific cytotoxic T cells
    • Gustafsson A, Levitsky V, Zou JZ, Frisan T, Dalianis T, Ljungman P, Ringden O, Winiarski J, Ernberg I, Masucci MG. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood 2000;95:807-814
    • (2000) Blood , vol.95 , pp. 807-814
    • Gustafsson, A.1    Levitsky, V.2    Zou, J.Z.3    Frisan, T.4    Dalianis, T.5    Ljungman, P.6    Ringden, O.7    Winiarski, J.8    Ernberg, I.9    Masucci, M.G.10
  • 55
    • 0028507899 scopus 로고
    • Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant
    • Porter D, Orloff G, Antin J. Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant. Transplant Sci. 1994;4:11-15.
    • (1994) Transplant Sci , vol.4 , pp. 11-15
    • Porter, D.1    Orloff, G.2    Antin, J.3
  • 58
    • 0026648439 scopus 로고
    • Restoration of viral immunity in immunodeficient humans by adoptive transfer of T cell clones
    • Riddell S, Watanabe K, Goodrich J, Li C, Agha M, Greenberg P. Restoration of viral immunity in immunodeficient humans by adoptive transfer of T cell clones. Science 1992;257:238-241
    • (1992) Science , vol.257 , pp. 238-241
    • Riddell, S.1    Watanabe, K.2    Goodrich, J.3    Li, C.4    Agha, M.5    Greenberg, P.6
  • 59
    • 0028820386 scopus 로고
    • Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
    • Walter E, Greenberg P, Gilbert M, Finch R, Watanabe K, Thomas E, Riddell S. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med. 1995; 333:1038-1044
    • (1995) N Engl J Med , vol.333 , pp. 1038-1044
    • Walter, E.1    Greenberg, P.2    Gilbert, M.3    Finch, R.4    Watanabe, K.5    Thomas, E.6    Riddell, S.7
  • 60
    • 0027998850 scopus 로고
    • Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation
    • Hromas R, Cornetta K, Srour E. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 1994;84(5):1689-1690
    • (1994) Blood , vol.84 , Issue.5 , pp. 1689-1690
    • Hromas, R.1    Cornetta, K.2    Srour, E.3
  • 64
    • 0027537527 scopus 로고
    • Delayed infusion of normal donor cells after MHCmatched bone marrow transplantation provides an antileukemia reaction without graftversus- host disease
    • Johnson B, Drobyski W, Truitt R. Delayed infusion of normal donor cells after MHCmatched bone marrow transplantation provides an antileukemia reaction without graftversus- host disease. Bone Marrow Transplant. 1993;11:329-336
    • (1993) Bone Marrow Transplant , vol.11 , pp. 329-336
    • Johnson, B.1    Drobyski, W.2    Truitt, R.3
  • 65
    • 0017111332 scopus 로고
    • Infusion of donor lymphocytes into stable canine radiation chimeras: Implications for mechanism of transplantation tolerance
    • Weiden P, Storb R, Tsoi M, Graham T, Lerner K, Thomas E. Infusion of donor lymphocytes into stable canine radiation chimeras: implications for mechanism of transplantation tolerance. J Immunol. 1978;116:1212-1219
    • (1978) J Immunol , vol.116 , pp. 1212-1219
    • Weiden, P.1    Storb, R.2    Tsoi, M.3    Graham, T.4    Lerner, K.5    Thomas, E.6
  • 66
    • 20244374668 scopus 로고    scopus 로고
    • Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant
    • Alyea E, Soiffer R, Canning C, Neuberg D, Schlossman R, Pickett C, Collins H, Wang Y, Anderson K, Ritz J. Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Blood 1998;91:3671-3680
    • (1998) Blood , vol.91 , pp. 3671-3680
    • Alyea, E.1    Soiffer, R.2    Canning, C.3    Neuberg, D.4    Schlossman, R.5    Pickett, C.6    Collins, H.7    Wang, Y.8    Anderson, K.9    Ritz, J.10
  • 68
    • 0035193114 scopus 로고    scopus 로고
    • Long-term follow-up of recipients of CD8 depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation
    • ShimoniA,Gajewski J,DonatoM,Martin T,O'Brien S, Talpaz M, CohenA,KorblingM, Champlin R, Giralt S. Long-term follow-up of recipients of CD8 depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation. Biol Blood Marrow Transplant. 2001; 7:568-575
    • (2001) Biol Blood Marrow Transplant , vol.7 , pp. 568-575
    • Shimoni, A.1    Gajewski, J.2    Donato, M.3    Martin, T.4    O'Brien, S.5    Talpaz, M.6    Cohen, A.7    Korbling, M.8    Champlin, R.9    Giralt, S.10
  • 69
    • 0033230957 scopus 로고    scopus 로고
    • Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease
    • Waller EK, Ship AM, Mittelstaedt S, Murray TW, Carter R, Kakhniashvili I, Lonial S, Holden JT, Boyer MW. Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease. Blood 1999;94:3222-3233
    • (1999) Blood , vol.94 , pp. 3222-3233
    • Waller, E.K.1    Ship, A.M.2    Mittelstaedt, S.3    Murray, T.W.4    Carter, R.5    Kakhniashvili, I.6    Lonial, S.7    Holden, J.T.8    Boyer, M.W.9
  • 70
    • 0032711448 scopus 로고    scopus 로고
    • Photochemical treatment with S-59 psoralen and ultraviolet: A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation
    • Truitt RL, Johnson BD, Hanke C, Talib S, Hearst JE. Photochemical treatment with S-59 psoralen and ultraviolet: a light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation. J Immunol. 1999;163:5145-5156
    • (1999) J Immunol , vol.163 , pp. 5145-5156
    • Truitt, R.L.1    Johnson, B.D.2    Hanke, C.3    Talib, S.4    Hearst, J.E.5
  • 75
    • 1542267219 scopus 로고    scopus 로고
    • Graft-versus-leukemia reactions in allogeneic chimeras
    • Kolb HJ, Schmid C, Barrett AJ, Schendel DJ. Graft-versus-leukemia reactions in allogeneic chimeras. Blood 2004;103:767-776
    • (2004) Blood , vol.103 , pp. 767-776
    • Kolb, H.J.1    Schmid, C.2    Barrett, A.J.3    Schendel, D.J.4
  • 78
    • 0024240238 scopus 로고
    • Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells
    • Voogt PJ,Goulmy E, VeenhofWF,HamiltonM, FibbeWE, Van Rood JJ, Falkenburg JH. Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells. J ExpMed. 1988;168:2337-2347
    • (1988) J ExpMed , vol.168 , pp. 2337-2347
    • Voogt, P.J.1    Goulmy, E.2    Veenhof, W.F.3    Hamilton, M.4    Fibbe, W.E.5    Van Rood, J.J.6    Falkenburg, J.H.7
  • 79
    • 0033120425 scopus 로고    scopus 로고
    • Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens
    • Mutis T, Verdijk R, Schrama E, Esendam B, Brand A, Goulmy E. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood 1999;93: 2336-2341
    • (1999) Blood , vol.93 , pp. 2336-2341
    • Mutis, T.1    Verdijk, R.2    Schrama, E.3    Esendam, B.4    Brand, A.5    Goulmy, E.6
  • 81
    • 9144219634 scopus 로고    scopus 로고
    • Ritz J.Antibody response toDBYminor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors
    • Miklos DB, Kim HT, Zorn E, Hochberg EP, Guo L, Mattes-Ritz A, Viatte S, Soiffer RJ, Antin JH, Ritz J.Antibody response toDBYminor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood 2004;103:353-359
    • (2004) Blood , vol.103 , pp. 353-359
    • Miklos, D.B.1    Kim, H.T.2    Zorn, E.3    Hochberg, E.P.4    Guo, L.5    Mattes-Ritz, A.6    Viatte, S.7    Soiffer, R.J.8    Antin, J.H.9
  • 82
    • 0346127456 scopus 로고    scopus 로고
    • Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants
    • Randolph SS, Gooley TA, Warren EH, Appelbaum FR, Riddell SR. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 2004;103:347-352
    • (2004) Blood , vol.103 , pp. 347-352
    • Randolph, S.S.1    Gooley, T.A.2    Warren, E.H.3    Appelbaum, F.R.4    Riddell, S.R.5
  • 83
    • 0029838112 scopus 로고    scopus 로고
    • Targeted T-cell therapy for human leukemia: Cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells
    • Molldrem J, Dermime S, Parker K, Jiang YZ, Mavroudis D, Hensel N, Fukushima P, Barrett AJ. Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood 1996;88:2450-2457
    • (1996) Blood , vol.88 , pp. 2450-2457
    • Molldrem, J.1    Dermime, S.2    Parker, K.3    Jiang, Y.Z.4    Mavroudis, D.5    Hensel, N.6    Fukushima, P.7    Barrett, A.J.8
  • 84
    • 0033826799 scopus 로고    scopus 로고
    • Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
    • Molldrem JJ, Lee PP, Wang C, Felio K, Kantarjian HM, Champlin RE, Davis MM. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med. 2000;6:1018-1023
    • (2000) Nat Med , vol.6 , pp. 1018-1023
    • Molldrem, J.J.1    Lee, P.P.2    Wang, C.3    Felio, K.4    Kantarjian, H.M.5    Champlin, R.E.6    Davis, M.M.7
  • 86
    • 0038780854 scopus 로고    scopus 로고
    • WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: Therapeutic potential of WT1 targeted therapies
    • Rosenfeld C, Cheever MA, Gaiger A. WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies. Leukemia 2003;17:1301-1312
    • (2003) Leukemia , vol.17 , pp. 1301-1312
    • Rosenfeld, C.1    Cheever, M.A.2    Gaiger, A.3
  • 91
    • 0031726010 scopus 로고    scopus 로고
    • Costimulatory approaches to adoptive immunotherapy
    • Liebowitz D, Lee K, CH J. Costimulatory approaches to adoptive immunotherapy. Curr Opin Oncol. 1998;10:533-541
    • (1998) Curr Opin Oncol , vol.10 , pp. 533-541
    • Liebowitz, D.1    Lee, K.2    Ch, J.3
  • 92
    • 0031573612 scopus 로고    scopus 로고
    • Effects of CD28 costimulation on long-termproliferation of CD4+ T cells in the absence of exogenous feeder cells
    • LevineBL, BernsteinWB,Connors M, CraigheadN, LindstenT, ThompsonCB, JuneCH. Effects of CD28 costimulation on long-termproliferation of CD4+ T cells in the absence of exogenous feeder cells. J Immunol. 1997;159:5921-5930
    • (1997) J Immunol , vol.159 , pp. 5921-5930
    • Levine, B.L.1    Bernstein, W.B.2    Connors, M.3    Craighead, N.4    Lindsten, T.5    Thompson, C.B.6    June, C.H.7
  • 95
    • 0032170052 scopus 로고    scopus 로고
    • Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation
    • Guillaume T, Rubinstein DB, Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 1998;92:1471-1490
    • (1998) Blood , vol.92 , pp. 1471-1490
    • Guillaume, T.1    Rubinstein, D.B.2    Symann, M.3
  • 97
    • 33748496886 scopus 로고    scopus 로고
    • Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders
    • Boulassel MR, Herr AL, de BEMD, Galal A, Lachance S, Laneuville P, Routy JP. Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders. Hematology 2006;11:165-170
    • (2006) Hematology , vol.11 , pp. 165-170
    • Boulassel, M.R.1    Herr, A.L.2    De Be, M.D.3    Galal, A.4    Lachance, S.5    Laneuville, P.6    Routy, J.P.7
  • 100
    • 11144299492 scopus 로고    scopus 로고
    • NK cell recognition
    • Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225-274
    • (2005) Annu Rev Immunol , vol.23 , pp. 225-274
    • Lanier, L.L.1
  • 101
    • 0019860635 scopus 로고
    • Natural killer cells: Their roles in defenses against disease
    • Herberman RB, Ortaldo J.R. Natural killer cells: their roles in defenses against disease. Science 1981;214:24-30.
    • (1981) Science , vol.214 , pp. 24-30
    • Herberman, R.B.1    Ortaldo, J.R.2
  • 102
    • 0016792586 scopus 로고
    • Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line
    • Kiessling R, Petranyi G, Klein G, Wigzel H. Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line. Int J Cancer. 1975;15:933-940
    • (1975) Int J Cancer , vol.15 , pp. 933-940
    • Kiessling, R.1    Petranyi, G.2    Klein, G.3    Wigzel, H.4
  • 103
    • 0023631856 scopus 로고
    • Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized
    • Murphy WJ, Kumar V, Bennett M. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J Exp Med. 1987;166:1499-1509
    • (1987) J Exp Med , vol.166 , pp. 1499-1509
    • Murphy, W.J.1    Kumar, V.2    Bennett, M.3
  • 104
    • 0015186224 scopus 로고
    • Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F1 hybrid mice
    • Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F1 hybrid mice. J Exp Med. 1971;134: 1513-1528
    • (1971) J Exp Med , vol.134 , pp. 1513-1528
    • Cudkowicz, G.1    Bennett, M.2
  • 106
    • 0021917804 scopus 로고
    • Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer
    • Rayner AA, Grimm EA, Lotze MT, Chu EW, Rosenberg SA. Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer. Cancer 1985;55:1327-1333
    • (1985) Cancer , vol.55 , pp. 1327-1333
    • Rayner, A.A.1    Grimm, E.A.2    Lotze, M.T.3    Chu, E.W.4    Rosenberg, S.A.5
  • 108
    • 0037313578 scopus 로고    scopus 로고
    • Interleukin-12 and the regulation of innate resistance and adaptive immunity
    • Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003;3:133-146
    • (2003) Nat Rev Immunol , vol.3 , pp. 133-146
    • Trinchieri, G.1
  • 109
    • 31144463847 scopus 로고    scopus 로고
    • Cytokines as critical co-stimulatory molecules in modulating the immune response of natural killer cells
    • DOI 10.1038/sj.cr.7310004, PII 7310004
    • Young HA, Ortaldo J. Cytokines as critical co-stimulatory molecules in modulating the immune response of natural killer cells. Cell Res. 2006;16:20-24. (Pubitemid 43129305)
    • (2006) Cell Research , vol.16 , Issue.1 , pp. 20-24
    • Young, H.A.1    Ortaldo, J.2
  • 110
    • 0033956722 scopus 로고    scopus 로고
    • Augmentation by interleukin-18 of MHC-nonrestricted killer activity of human peripheral blood mononuclear cells in response to interleukin-12
    • Singh SM, Yanagawa H, Hanibuchi M, Miki T, Okamura H, Sone S. Augmentation by interleukin-18 of MHC-nonrestricted killer activity of human peripheral blood mononuclear cells in response to interleukin-12. Int J Immunopharmacol. 2000;22:35-43.
    • (2000) Int J Immunopharmacol , vol.22 , pp. 35-43
    • Singh, S.M.1    Yanagawa, H.2    Hanibuchi, M.3    Miki, T.4    Okamura, H.5    Sone, S.6
  • 111
    • 26844581032 scopus 로고    scopus 로고
    • Natural-killer cells and dendritic cells: L'union fait la force
    • Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E. Natural-killer cells and dendritic cells: "l'union fait la force". Blood 2005;106:2252-2258
    • (2005) Blood , vol.106 , pp. 2252-2258
    • Walzer, T.1    Dalod, M.2    Robbins, S.H.3    Zitvogel, L.4    Vivier, E.5
  • 112
    • 33746276811 scopus 로고    scopus 로고
    • Killer cell Ig-like receptors ligandmismatched, alloreactive natural killer cells lyse primary solid tumors
    • Re F, Staudacher C, Zamai L, Vecchio V, Bregni M. Killer cell Ig-like receptors ligandmismatched, alloreactive natural killer cells lyse primary solid tumors. Cancer 2006;107:640-648
    • (2006) Cancer , vol.107 , pp. 640-648
    • Re, F.1    Staudacher, C.2    Zamai, L.3    Vecchio, V.4    Bregni, M.5
  • 114
    • 0036217977 scopus 로고    scopus 로고
    • Lymphocyte-mediated cytotoxicity
    • Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol. 2002; 20:323-370
    • (2002) Annu Rev Immunol , vol.20 , pp. 323-370
    • Russell, J.H.1    Ley, T.J.2
  • 115
    • 0023792164 scopus 로고
    • Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes
    • Lanier LL, Ruitenberg JJ, Phillips JH. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J Immunol. 1988;141:3478-3485
    • (1988) J Immunol , vol.141 , pp. 3478-3485
    • Lanier, L.L.1    Ruitenberg, J.J.2    Phillips, J.H.3
  • 117
    • 0037654923 scopus 로고    scopus 로고
    • Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family
    • Yawata M, Yawata N, Abi-Rached L, Parham P. Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family. Crit Rev Immunol. 2002;22:463-482
    • (2002) Crit Rev Immunol , vol.22 , pp. 463-482
    • Yawata, M.1    Yawata, N.2    Abi-Rached, L.3    Parham, P.4
  • 118
    • 0345735835 scopus 로고    scopus 로고
    • The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1
    • PandoMJ, Gardiner CM, GleimerM,McQueen KL, Parham P. The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol. 2003;171:6640-6649
    • (2003) J Immunol , vol.171 , pp. 6640-6649
    • Pando, M.J.1    Gardiner, C.M.2    Gleimer, M.3    McQueen, K.L.4    Parham, P.5
  • 120
    • 0032169449 scopus 로고    scopus 로고
    • Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors
    • DOI 10.1016/S1074-7613(00)80616-0
    • Vales-Gomez M, Reyburn HT, Mandelboim M, Strominger JL. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. Immunity 1998;9:337-344 (Pubitemid 28462754)
    • (1998) Immunity , vol.9 , Issue.3 , pp. 337-344
    • Vales-Gomez, M.1    Reyburn, H.T.2    Mandelboim, M.3    Strominger, J.L.4
  • 121
    • 0025754310 scopus 로고
    • DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells
    • Houchins JP, Yabe T, McSherry C, Bach FH. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med. 1991;173:1017-1020
    • (1991) J Exp Med , vol.173 , pp. 1017-1020
    • Houchins, J.P.1    Yabe, T.2    McSherry, C.3    Bach, F.H.4
  • 122
    • 1542359026 scopus 로고    scopus 로고
    • Natural killer cell receptors for major histocompatibility complex class i and related molecules in cytomegalovirus infection
    • Lopez-Botet M, Angulo A, Guma M. Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. Tissue Antigens. 2004;63:195-203.
    • (2004) Tissue Antigens , vol.63 , pp. 195-203
    • Lopez-Botet, M.1    Angulo, A.2    Guma, M.3
  • 123
    • 34547132338 scopus 로고    scopus 로고
    • RAET1E2, a soluble isoform of the UL16 binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity
    • Cao W, Xi X, Hao Z, Li W, Kong Y, Cui L, Ma C, Ba D, He W. RAET1E2, a soluble isoform of the UL16 binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity. J Biol Chem. 2007;282:18922-18928
    • (2007) J Biol Chem , vol.282 , pp. 18922-18928
    • Cao, W.1    Xi, X.2    Hao, Z.3    Li, W.4    Kong, Y.5    Cui, L.6    Ma, C.7    Ba, D.8    He, W.9
  • 124
    • 44949266455 scopus 로고
    • In search of the "missing self": MHC molecules and NK cell recognition
    • Ljunggren HG, Karre K. In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today. 1990;11:237-244
    • (1990) Immunol Today , vol.11 , pp. 237-244
    • Ljunggren, H.G.1    Karre, K.2
  • 126
    • 0035056004 scopus 로고    scopus 로고
    • Regulation of the natural killer cell receptor repertoire
    • Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol. 2001;19:291-330.
    • (2001) Annu Rev Immunol , vol.19 , pp. 291-330
    • Raulet, D.H.1    Vance, R.E.2    McMahon, C.W.3
  • 127
    • 18844365992 scopus 로고    scopus 로고
    • Asubset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules
    • Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH.Asubset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 2005;105:4416-4423
    • (2005) Blood , vol.105 , pp. 4416-4423
    • Fernandez, N.C.1    Treiner, E.2    Vance, R.E.3    Jamieson, A.M.4    Lemieux, S.5    Raulet, D.H.6
  • 133
    • 33847183077 scopus 로고    scopus 로고
    • Cooperation of toll-like receptor signals in innate immune defence
    • Trinchieri G, Sher A. Cooperation of toll-like receptor signals in innate immune defence. Nat Rev Immunol. 2007;7:179-190
    • (2007) Nat Rev Immunol , vol.7 , pp. 179-190
    • Trinchieri, G.1    Sher, A.2
  • 134
    • 0035437190 scopus 로고    scopus 로고
    • Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2
    • Miller JS, McCullar V. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood 2001;98:705-713
    • (2001) Blood , vol.98 , pp. 705-713
    • Miller, J.S.1    McCullar, V.2
  • 135
    • 0032533237 scopus 로고    scopus 로고
    • Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15
    • Yu H, Fehniger TA, Fuchshuber P, Thiel KS, Vivier E, Carson WE, Caligiuri MA. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. Blood 1998;92:3647-3657
    • (1998) Blood , vol.92 , pp. 3647-3657
    • Yu, H.1    Fehniger, T.A.2    Fuchshuber, P.3    Thiel, K.S.4    Vivier, E.5    Carson, W.E.6    Caligiuri, M.A.7
  • 136
    • 0033827910 scopus 로고    scopus 로고
    • Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocytemacrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors
    • Muench MO, Humeau L, Paek B, Ohkubo T, Lanier LL, Albanese CT, Barcena A. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocytemacrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors. Exp Hematol. 2000;28:961-973
    • (2000) Exp Hematol , vol.28 , pp. 961-973
    • Muench, M.O.1    Humeau, L.2    Paek, B.3    Ohkubo, T.4    Lanier, L.L.5    Albanese, C.T.6    Barcena, A.7
  • 139
    • 15444369238 scopus 로고    scopus 로고
    • Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3
    • Trompeter HI, Gomez-Lozano N, Santourlidis S, Eisermann B, Wernet P, Vilches C, Uhrberg M. Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3. J Immunol. 2005;174:4135-4143
    • (2005) J Immunol , vol.174 , pp. 4135-4143
    • Trompeter, H.I.1    Gomez-Lozano, N.2    Santourlidis, S.3    Eisermann, B.4    Wernet, P.5    Vilches, C.6    Uhrberg, M.7
  • 141
    • 0141886193 scopus 로고    scopus 로고
    • KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production
    • Kikuchi-Maki A, Yusa S, Catina TL, Campbell KS. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol. 2003;171:3415-3425
    • (2003) J Immunol , vol.171 , pp. 3415-3425
    • Kikuchi-Maki, A.1    Yusa, S.2    Catina, T.L.3    Campbell, K.S.4
  • 142
    • 1842858906 scopus 로고    scopus 로고
    • A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey
    • Maxwell LD, Wallace A, Middleton D, Curran MD. A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 2002;60:254-258
    • (2002) Tissue Antigens , vol.60 , pp. 254-258
    • Maxwell, L.D.1    Wallace, A.2    Middleton, D.3    Curran, M.D.4
  • 143
  • 144
    • 28844436009 scopus 로고    scopus 로고
    • KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation
    • Cooley S, McCullar V, Wangen R, Bergemann TL, Spellman S, Weisdorf DJ, Miller JS. KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood 2005;106:4370-4376
    • (2005) Blood , vol.106 , pp. 4370-4376
    • Cooley, S.1    McCullar, V.2    Wangen, R.3    Bergemann, T.L.4    Spellman, S.5    Weisdorf, D.J.6    Miller, J.S.7
  • 145
    • 33750730609 scopus 로고    scopus 로고
    • Activation and self-tolerance of natural killer cells
    • Gasser S, Raulet DH. Activation and self-tolerance of natural killer cells. Immunol Rev. 2006;214:130-142
    • (2006) Immunol Rev , vol.214 , pp. 130-142
    • Gasser, S.1    Raulet, D.H.2
  • 147
    • 33750735022 scopus 로고    scopus 로고
    • Licensing of natural killer cells by self-major histocompatibility complex class i
    • YokoyamaWM,Kim S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev. 2006;214:143-154
    • (2006) Immunol Rev , vol.214 , pp. 143-154
    • Yokoyama, W.M.1    Kim, S.2
  • 148
    • 33750721289 scopus 로고    scopus 로고
    • Taking license with natural killer cell maturation and repertoire development
    • Parham P. Taking license with natural killer cell maturation and repertoire development. Immunol Rev. 2006;214:155-160
    • (2006) Immunol Rev , vol.214 , pp. 155-160
    • Parham, P.1
  • 149
    • 0023115642 scopus 로고
    • A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone
    • Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med. 1987;316:889-897
    • (1987) N Engl J Med , vol.316 , pp. 889-897
    • Rosenberg, S.A.1    Lotze, M.T.2    Muul, L.M.3    Chang, A.E.4    Avis, F.P.5    Leitman, S.6    Linehan, W.M.7    Robertson, C.N.8    Lee, R.E.9    Rubin, J.T.10
  • 156
    • 0032885461 scopus 로고    scopus 로고
    • Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu
    • Cooley S, Burns LJ, Repka T, Miller JS. Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu. Exp Hematol. 1999;27:1533-1541
    • (1999) Exp Hematol , vol.27 , pp. 1533-1541
    • Cooley, S.1    Burns, L.J.2    Repka, T.3    Miller, J.S.4
  • 158
    • 33845948119 scopus 로고    scopus 로고
    • Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy
    • Ohira M, Ohdan H, Mitsuta H, Ishiyama K, Tanaka Y, Igarashi Y, Asahara T. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy. Transplantation 2006;82: 1712-1719
    • (2006) Transplantation , vol.82 , pp. 1712-1719
    • Ohira, M.1    Ohdan, H.2    Mitsuta, H.3    Ishiyama, K.4    Tanaka, Y.5    Igarashi, Y.6    Asahara, T.7
  • 159
    • 8844228916 scopus 로고    scopus 로고
    • Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation
    • Passweg JR, Tichelli A, Meyer-Monard S, Heim D, Stern M, Kuhne T, Favre G, Gratwohl A. Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation. Leukemia 2004;18:1835-1838
    • (2004) Leukemia , vol.18 , pp. 1835-1838
    • Passweg, J.R.1    Tichelli, A.2    Meyer-Monard, S.3    Heim, D.4    Stern, M.5    Kuhne, T.6    Favre, G.7    Gratwohl, A.8
  • 164
    • 33748333186 scopus 로고    scopus 로고
    • Novel approaches using natural killer cells in cancer therapy
    • Suck G. Novel approaches using natural killer cells in cancer therapy. Semin Cancer Biol. 2006;16:412-418
    • (2006) Semin Cancer Biol , vol.16 , pp. 412-418
    • Suck, G.1
  • 165
    • 0037103311 scopus 로고    scopus 로고
    • Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction
    • Uherek C, Tonn T, Uherek B, Becker S, Schnierle B, Klingemann HG, Wels W. Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction. Blood 2002;100:1265-1273
    • (2002) Blood , vol.100 , pp. 1265-1273
    • Uherek, C.1    Tonn, T.2    Uherek, B.3    Becker, S.4    Schnierle, B.5    Klingemann, H.G.6    Wels, W.7
  • 166
    • 0141678976 scopus 로고    scopus 로고
    • Induction of allopeptide-specific human CD4+ CD25+ regulatory T cells ex vivo
    • Jiang S, Camara N, Lombardi G, Lechler RI. Induction of allopeptide-specific human CD4+ CD25+ regulatory T cells ex vivo. Blood 2003;102:2180-2186
    • (2003) Blood , vol.102 , pp. 2180-2186
    • Jiang, S.1    Camara, N.2    Lombardi, G.3    Lechler, R.I.4
  • 168
    • 0141461418 scopus 로고    scopus 로고
    • CD4+ CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. [see comment]
    • Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, Negrin RS. CD4+ CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. [see comment]. Nat Med. 2003;9:1144-1150
    • (2003) Nat Med , vol.9 , pp. 1144-1150
    • Edinger, M.1    Hoffmann, P.2    Ermann, J.3    Drago, K.4    Fathman, C.G.5    Strober, S.6    Negrin, R.S.7
  • 170
    • 20444373376 scopus 로고    scopus 로고
    • Rapamycin selectively expands CD4+ CD25+ FoxP3+ regulatory T cells
    • Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands CD4+ CD25+ FoxP3+ regulatory T cells. Blood 2005;105:4743-4748
    • (2005) Blood , vol.105 , pp. 4743-4748
    • Battaglia, M.1    Stabilini, A.2    Roncarolo, M.G.3
  • 171
    • 34047130792 scopus 로고    scopus 로고
    • Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis
    • Keever-Taylor CA, Browning MB, Johnson BD, Truitt RL, Bredeson CN, Behn B, Tsao A. Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis. Cytotherapy 2007;9:144-157
    • (2007) Cytotherapy , vol.9 , pp. 144-157
    • Keever-Taylor, C.A.1    Browning, M.B.2    Johnson, B.D.3    Truitt, R.L.4    Bredeson, C.N.5    Behn, B.6    Tsao, A.7
  • 172
    • 34547214205 scopus 로고    scopus 로고
    • Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans
    • Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol. 2007;7:585-598
    • (2007) Nat Rev Immunol , vol.7 , pp. 585-598
    • Roncarolo, M.G.1    Battaglia, M.2
  • 176
    • 0031861531 scopus 로고    scopus 로고
    • Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells
    • Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol. 1998;176:57-66.
    • (1998) J Cell Physiol , vol.176 , pp. 57-66
    • Majumdar, M.K.1    Thiede, M.A.2    Mosca, J.D.3    Moorman, M.4    Gerson, S.L.5
  • 177
    • 0042740515 scopus 로고    scopus 로고
    • Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex
    • Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol. 2003;57:11-20.
    • (2003) Scand J Immunol , vol.57 , pp. 11-20
    • Le Blanc, K.1    Tammik, L.2    Sundberg, B.3    Haynesworth, S.E.4    Ringden, O.5
  • 178
    • 13544249606 scopus 로고    scopus 로고
    • Human mesenchymal stem cells modulate allogeneic immune cell responses
    • Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-1822
    • (2005) Blood , vol.105 , pp. 1815-1822
    • Aggarwal, S.1    Pittenger, M.F.2
  • 181
    • 0033977382 scopus 로고    scopus 로고
    • Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and cultureexpanded marrow mesenchymal stem cells in advanced breast cancer patients receiving highdose chemotherapy
    • KocON,Gerson SL,Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and cultureexpanded marrow mesenchymal stem cells in advanced breast cancer patients receiving highdose chemotherapy. J Clin Oncol. 2000;18:307-316
    • (2000) J Clin Oncol , vol.18 , pp. 307-316
    • Koc, O.N.1    Gerson, S.L.2    Cooper, B.W.3    Dyhouse, S.M.4    Haynesworth, S.E.5    Caplan, A.I.6    Lazarus, H.M.7
  • 182
    • 2342482526 scopus 로고    scopus 로고
    • Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
    • Le BlancK,Rasmusson I, Sundberg B,GotherstromC,HassanM,UzunelM,Ringden O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-1441
    • (2004) Lancet , vol.363 , pp. 1439-1441
    • Le Blanc, K.1    Rasmusson, I.2    Sundberg, B.3    Gotherstrom, C.4    Hassan, M.5    Uzunel, M.6    Ringden, O.7
  • 185
    • 0037105453 scopus 로고    scopus 로고
    • Natural killer cell receptors: New biology and insights into the graft-versus-leukemia effect
    • Farag SS, Fehniger TA, Ruggeri L, VelardiA, CaligiuriMA.Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 2002; 100:1935-1947
    • (2002) Blood , vol.100 , pp. 1935-1947
    • Farag, S.S.1    Fehniger, T.A.2    Ruggeri, L.3    Velardi, A.4    Caligiuri, M.A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.